{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:14:22Z","timestamp":1792088062141,"version":"4.4.0"},"reference-count":111,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008320","name":"Association de Recherche sur la Polyarthrite","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008320","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"publisher","award":["2018\/19523-7"],"award-info":[{"award-number":["2018\/19523-7"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"publisher","award":["2023\/05739-6"],"award-info":[{"award-number":["2023\/05739-6"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nitric Oxide"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.niox.2024.05.003","type":"journal-article","created":{"date-parts":[[2024,5,26]],"date-time":"2024-05-26T05:23:51Z","timestamp":1716701031000},"page":"7-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Endothelial dysfunction in Sickle Cell Disease: Strategies for the treatment"],"prefix":"10.1016","volume":"149","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4932-7720","authenticated-orcid":false,"given":"Aline Renata","family":"Pavan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Terroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Leandro","family":"Dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.niox.2024.05.003_bib1","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1001\/archinte.1910.00050330050003","article-title":"Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia","author":"Herrick","year":"1910","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.niox.2024.05.003_bib2","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1126\/science.110.2846.64","article-title":"The inheritance of sickle cell anemia","volume":"110","author":"Neel","year":"1949","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.niox.2024.05.003_bib3","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1074\/jbc.M003649200","article-title":"Loss of phospholipid asymmetry and surface exposure of phosphatidylserine is required for phagocytosis of apoptotic cells by macrophages and fibroblasts","volume":"276","author":"Fadok","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.niox.2024.05.003_bib4","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/ajh.23232","article-title":"Genetic modifiers of sickle cell disease","volume":"87","author":"Steinberg","year":"2012","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.niox.2024.05.003_bib5","series-title":"Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management","first-page":"201","article-title":"Mechanisms and clinical complications of hemolysis in sickle cell disease and thalassemia","author":"Kato","year":"2009"},{"key":"10.1016\/j.niox.2024.05.003_bib6","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1172\/JCI118074","article-title":"Nitric oxide decreases cytokine-induced endothelial activation nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines","volume":"96","author":"Caterina","year":"1995","journal-title":"Am. Soc. Clin. Investig."},{"issue":"6","key":"10.1016\/j.niox.2024.05.003_bib7","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1365-2141.2005.05701.x","article-title":"Levels of soluble endothelium-derived adhesion molecules in patients with sickle cell disease are associated with pulmonary hypertension, organ dysfunction, and mortality","volume":"130","author":"Kato","year":"2005","journal-title":"Br. J. Haematol."},{"issue":"3","key":"10.1016\/j.niox.2024.05.003_bib8","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/jcp.22195","article-title":"Sickle cell anemia and vascular dysfunction: the nitric oxide connection","volume":"224","author":"Akinsheye","year":"2010","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.niox.2024.05.003_bib9","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1046\/j.1523-1755.2000.00039.x","article-title":"Exposure of endothelial cells to recombinant human erythropoietin induces nitric oxide synthase activity","volume":"57","author":"Banerjee","year":"2000","journal-title":"Kidney Int."},{"issue":"12","key":"10.1016\/j.niox.2024.05.003_bib10","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/nm1202-799","article-title":"Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease","volume":"8","author":"Reiter","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.niox.2024.05.003_bib11","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.bcmd.2010.02.005","article-title":"Plasma asymmetric dimethylarginine concentrations in sickle cell disease are related to the hemolytic phenotype","volume":"44","author":"Landburg","year":"2010","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.niox.2024.05.003_bib12","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/0006-2952(89)90403-6","article-title":"A pathway for commentary of nitric oxide from L-arginine the regulation of cell function and communication","volume":"38","author":"Moncada","year":"1989","journal-title":"Biochem. Pharmacol."},{"issue":"13","key":"10.1016\/j.niox.2024.05.003_bib13","first-page":"1491","article-title":"Biological activity of hemoprotein nitrosyl complexes","volume":"72","author":"Osipov","year":"2007","journal-title":"Usp. Biol. Khim."},{"key":"10.1016\/j.niox.2024.05.003_bib14","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.atherosclerosis.2014.09.001","article-title":"Vascular oxidative stress, nitric oxide and atherosclerosis","volume":"237","author":"Li","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.niox.2024.05.003_bib15","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.niox.2015.02.145","article-title":"Skeletal muscle as an endogenous nitrate reservoir","volume":"47","author":"Piknova","year":"2015","journal-title":"Nitric Oxide - Biol. Chem."},{"issue":"8","key":"10.1016\/j.niox.2024.05.003_bib16","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/nm0895-804","article-title":"Enzyme-independent formation of nitric oxide in biological tissues","volume":"1","author":"Zweier","year":"1995","journal-title":"Nat. Med."},{"issue":"12","key":"10.1016\/j.niox.2024.05.003_bib17","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1038\/nm954","article-title":"Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation","volume":"9","author":"Cosby","year":"2003","journal-title":"Nat. Med."},{"issue":"26","key":"10.1016\/j.niox.2024.05.003_bib18","doi-asserted-by":"crossref","first-page":"17855","DOI":"10.1074\/jbc.M801785200","article-title":"Nitric oxide production from nitrite occurs primarily in tissues not in the blood: critical role of xanthine oxidase and aldehyde oxidase","volume":"283","author":"Li","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.niox.2024.05.003_bib19","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1089\/ars.2007.1989","article-title":"Nitric oxide, tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension","volume":"10","author":"Schulz","year":"2008","journal-title":"Antioxidants Redox Signal."},{"issue":"9","key":"10.1016\/j.niox.2024.05.003_bib20","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.3324\/haematol.12928","article-title":"Association of asymmetric dimethylarginine with sickle cell disease-related pulmonary hypertension","volume":"93","author":"Landburg","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.niox.2024.05.003_bib21","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/306174a0","article-title":"Endothelium-dependent relaxation in rat aorta may Be mediated through cyclic GMP-dependent protein phosphorylation","volume":"10","author":"Rapoport","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.niox.2024.05.003_bib22","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0008-6363(02)00327-9","article-title":"Vasoprotection by nitric oxide: mechanisms and therapeutic potential","volume":"55","author":"Gewaltig","year":"2002","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.niox.2024.05.003_bib23","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/368850a0","article-title":"Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle","volume":"368","author":"Bolotina","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.niox.2024.05.003_bib24","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1161\/01.RES.84.2.210","article-title":"Mechanism of nitric oxide-induced vasodilatation: refilling of intracellular stores by sarcoplasmic reticulum Ca2+ ATPase and inhibition of store-operated Ca2+ influx","volume":"84","author":"Cohen","year":"1999","journal-title":"Circ. Res."},{"key":"10.1016\/j.niox.2024.05.003_bib25","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.ejmech.2018.03.046","article-title":"Inhibitors of phosphodiesterase as cancer therapeutics","volume":"150","author":"Peng","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"29","key":"10.1016\/j.niox.2024.05.003_bib26","doi-asserted-by":"crossref","first-page":"26480","DOI":"10.1074\/jbc.M302238200","article-title":"Macrophage endothelial nitric-oxide synthase autoregulates cellular activation and pro-inflammatory protein expression","volume":"278","author":"Connelly","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.niox.2024.05.003_bib27","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1146\/annurev.ph.57.030195.003513","article-title":"Nitric oxide: pathophysiological mechanisms","volume":"57","author":"Gross","year":"1995","journal-title":"Annu. Rev. Physiol."},{"issue":"1","key":"10.1016\/j.niox.2024.05.003_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15171\/ipp.2019.08","article-title":"The role of nitric oxide in inflammation and oxidative stress","volume":"5","author":"Papi","year":"2019","journal-title":"Immunopathol. Persa"},{"key":"10.1016\/j.niox.2024.05.003_bib29","first-page":"291","article-title":"Roles of nitric oxide and superoxide in inflammation","volume":"225","author":"Salvemini","year":"2003","journal-title":"Methods Mol. Biol."},{"issue":"5","key":"10.1016\/j.niox.2024.05.003_bib30","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1182\/asheducation-2008.1.177","article-title":"Mechanisms of vasculopathy in sickle cell disease and thalassemia","author":"Morris","year":"2008","journal-title":"Hematol. Am Soc Hematol Educ Progr."},{"key":"10.1016\/j.niox.2024.05.003_bib31","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/S1567-5769(01)00086-8","article-title":"Nitric oxide in immunity and inflammation","volume":"1","author":"Coleman","year":"2001","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.niox.2024.05.003_bib32","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/10739680490278402","article-title":"The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathy","volume":"11","author":"Hebbel","year":"2004","journal-title":"Microcirculation"},{"key":"10.1016\/j.niox.2024.05.003_bib33","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.bcmd.2017.05.009","article-title":"Oxidative pathways in the sickle cell and beyond","volume":"70","author":"Alayash","year":"2018","journal-title":"Blood Cells Mol. Dis."},{"issue":"5","key":"10.1016\/j.niox.2024.05.003_bib34","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1182\/blood-2008-03-142604","article-title":"Proteomic identification of altered apolipoprotein patterns in pulmonary hypertension and vasculopathy of sickle cell disease","volume":"113","author":"Yuditskaya","year":"2009","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.niox.2024.05.003_bib35","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.lfs.2014.08.021","article-title":"Reduced plasma angiotensin II levels are reversed by hydroxyurea treatment in mice with sickle cell disease","volume":"117","author":"dos Santos","year":"2014","journal-title":"Life Sci."},{"key":"10.1016\/j.niox.2024.05.003_bib36","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/ajh.20107","article-title":"Vasoactive factors in sickle cell disease: in vitro evidence for endothelin-1-mediated vasoconstriction","volume":"76","author":"Ergul","year":"2004","journal-title":"Am. J. Hematol."},{"issue":"4","key":"10.1016\/j.niox.2024.05.003_bib37","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1042\/CS20120030","article-title":"Update on new aspects of the renin-angiotensin system in liver disease: clinical implications and new therapeutic options","volume":"123","author":"Grace","year":"2012","journal-title":"Clin Sci"},{"key":"10.1016\/j.niox.2024.05.003_bib38","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.krcp.2013.12.001","article-title":"Kidney research and clinical practice effects of oxidative stress on endothelial modulation of contractions in aorta from renal hypertensive rats","volume":"33","author":"Choi","year":"2014","journal-title":"Kidney Res. Clin. Pract."},{"key":"10.1016\/j.niox.2024.05.003_bib39","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.semnephrol.2004.04.008","article-title":"Nitric oxide, angiotensin II, and hypertension","volume":"24","author":"Zhou","year":"2004","journal-title":"Semin. Nephrol."},{"issue":"5","key":"10.1016\/j.niox.2024.05.003_bib40","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/FJC.0000000000000570","article-title":"New nitric oxide donor NCX 1443: therapeutic effects on pulmonary hypertension in the SAD mouse model of sickle cell disease","volume":"71","author":"Abid","year":"2018","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"4","key":"10.1016\/j.niox.2024.05.003_bib41","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3324\/haematol.12119","article-title":"Increased adhesive properties of neutrophils in sickle cell disease may Be reversed by pharmacological nitric oxide donation","volume":"93","author":"Canalli","year":"2008","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.niox.2024.05.003_bib42","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/j.1365-2141.2008.07259.x","article-title":"Sodium nitrite promotes regional blood flow in patients with sickle cell disease: a phase I\/II study","volume":"142","author":"Mack","year":"2008","journal-title":"Br. J. Haematol."},{"issue":"3","key":"10.1016\/j.niox.2024.05.003_bib43","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0008-6363(00)00078-X","article-title":"Status of myocardial antioxidants in ischemia-reperfusion injury","volume":"47","author":"Dhalla","year":"2000","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.niox.2024.05.003_bib44","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.bbrc.2008.08.102","article-title":"Cysteine-iron promotes arginase activity by driving the fenton reaction","volume":"376","author":"Iyamu","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.niox.2024.05.003_bib45","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1213\/ANE.0000000000001378","article-title":"Arginase inhibition reverses endothelial dysfunction, pulmonary hypertension and vascular stiffness in transgenic sickle cell mice","volume":"123","author":"Steppan","year":"2016","journal-title":"Anesth. Analg."},{"issue":"2","key":"10.1016\/j.niox.2024.05.003_bib46","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1365-2141.2007.06798.x","article-title":"In vitro evidence of the inhibitory capacity of chloroquine on arginase activity in sickle erythrocytes","volume":"139","author":"Iyamu","year":"2007","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.niox.2024.05.003_bib47","doi-asserted-by":"crossref","DOI":"10.1152\/ajpheart.00162.2008","article-title":"Arginine therapy of transgenic-knockout sickle mice improves microvascular function by reducing non-nitriv oxide vasodilators, hemolysis, and oxidative stress","volume":"295","author":"Kaul","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.niox.2024.05.003_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/4397150","article-title":"Double-blind clinical trial of arginine supplementation in the treatment of adult patients with sickle cell anaemia","volume":"2019","author":"Eleut\u00e9rio","year":"2019","journal-title":"Adv. Hematol."},{"key":"10.1016\/j.niox.2024.05.003_bib49","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.niox.2017.12.009","article-title":"A pilot study of a non-invasive oral nitrate stable isotopic method suggests that arginine and citrulline supplementation increases whole-body NO production in Tanzanian children with sickle cell disease","volume":"74","author":"Marealle","year":"2018","journal-title":"Nitric Oxide - Biol. Chem."},{"issue":"4","key":"10.1016\/j.niox.2024.05.003_bib50","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/S2352-3026(18)30020-6","article-title":"Ready-to-Use food supplement, with or without arginine and citrulline, with daily chloroquine in Tanzanian children with sickle-cell disease: a double-blind, random order crossover trial","volume":"5","author":"Cox","year":"2018","journal-title":"Lancet Haematol"},{"issue":"4","key":"10.1016\/j.niox.2024.05.003_bib51","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1600-0609.2009.01210.x","article-title":"Hematologic, biochemical, and cardiopulmonary effects of l-arginine supplementation or phosphodiesterase 5 inhibition in patients with sickle cell disease who are on hydroxyurea therapy","volume":"82","author":"Little","year":"2009","journal-title":"Eur. J. Haematol."},{"issue":"5","key":"10.1016\/j.niox.2024.05.003_bib52","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/phar.1592","article-title":"Riociguat: a novel new drug for treatment of pulmonary hypertension","volume":"35","author":"Makowski","year":"2015","journal-title":"Pharmacotherapy"},{"issue":"4","key":"10.1016\/j.niox.2024.05.003_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/2045894018791802","article-title":"Riociguat use in sickle cell related chronic thromboembolic pulmonary hypertension: a case series","volume":"8","author":"Weir","year":"2018","journal-title":"Pulm. Circ."},{"key":"10.1016\/j.niox.2024.05.003_bib54","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1182\/blood-2018-99-116011","article-title":"The effect of the soluble guanylyl cyclase stimulator olinciguat on ?-globin gene induction in K562 cells","volume":"132","author":"Miyashiro","year":"2018","journal-title":"Blood"},{"issue":"17","key":"10.1016\/j.niox.2024.05.003_bib55","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1111\/bph.15492","article-title":"Olinciguat, a stimulator of soluble guanylyl cyclase, attenuates inflammation, vaso-occlusion and nephropathy in mouse models of sickle cell disease","volume":"178","author":"Tchernychev","year":"2021","journal-title":"Br. J. Pharmacol."},{"issue":"18","key":"10.1016\/j.niox.2024.05.003_bib56","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1161\/01.CIR.0000070589.61860.A9","article-title":"L-4F, an apolipoprotein A-1 mimetic, dramatically improves vasodilation in hypercholesterolemia and sickle cell disease","volume":"107","author":"Ou","year":"2003","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.niox.2024.05.003_bib57","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/j.amjcard.2013.06.035","article-title":"Effect of extended release niacin on serum lipids and on endothelial function in adults with sickle cell anemia and low high-density lipoprotein cholesterol levels","volume":"112","author":"Scoffone","year":"2013","journal-title":"Am. J. Cardiol."},{"issue":"1","key":"10.1016\/j.niox.2024.05.003_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12944-019-1174-5","article-title":"Altered HDL particle in sickle cell disease: decreased cholesterol content is associated with hemolysis, whereas decreased apolipoprotein A1 is linked to inflammation","volume":"18","author":"Yalcinkaya","year":"2019","journal-title":"Lipids Health Dis."},{"issue":"9","key":"10.1016\/j.niox.2024.05.003_bib59","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.3324\/haematol.2009.018044","article-title":"Apolipoprotein A-I and serum amyloid a plasma levels are biomarkers of acute painful episodes in patients with sickle cell disease","volume":"95","author":"Tumblin","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.niox.2024.05.003_bib60","first-page":"412","article-title":"Biology of disease: free radicals and tissue injury","volume":"47","author":"Freeman","year":"1982","journal-title":"Lab. Invest."},{"issue":"9","key":"10.1016\/j.niox.2024.05.003_bib61","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1182\/blood.V91.9.3467","article-title":"Comparative oxidation of hemoglobins A and S","volume":"91","author":"Sheng","year":"1998","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.niox.2024.05.003_bib62","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1073\/pnas.85.1.237","article-title":"Accelerated autoxidation and heme loss due to instability of sickle hemoglobin","volume":"85","author":"Hebbel","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.niox.2024.05.003_bib63","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1172\/JCI89741","article-title":"Intravascular hemolysis and the pathophysiology of sickle cell disease","volume":"127","author":"Kato","year":"2017","journal-title":"J. Clin. Invest."},{"issue":"March","key":"10.1016\/j.niox.2024.05.003_bib64","first-page":"1","article-title":"The red blood cell\u2014inflammation vicious circle in sickle cell disease","volume":"11","author":"Nader","year":"2020","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.niox.2024.05.003_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/ajplung.00252.2014","article-title":"Vasculopathy and pulmonary hypertension in sickle cell disease","volume":"308","author":"Potoka","year":"2015","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"issue":"2","key":"10.1016\/j.niox.2024.05.003_bib66","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/1535370219827276","article-title":"CGMP modulation therapeutics for sickle cell disease","volume":"244","author":"Conran","year":"2019","journal-title":"Exp. Biol. Med."},{"issue":"3","key":"10.1016\/j.niox.2024.05.003_bib67","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.bcmd.2011.01.002","article-title":"Assessment of oxidative stress in patients with sickle cell disease: the glutathione system and the oxidant-antioxidant status","volume":"46","author":"Gizi","year":"2011","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.niox.2024.05.003_bib68","first-page":"48","article-title":"Plasma levels of retinol, ascorbic acid and alpha-tocopherol in sickle cell anaemia","volume":"41","author":"Essien","year":"1995","journal-title":"Cent. Afr. J. Med."},{"issue":"1","key":"10.1016\/j.niox.2024.05.003_bib69","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5144\/0256-4947.2006.17","article-title":"Zinc and antioxidant vitamin deficiency in patients with severe sickle cell anemia","volume":"26","author":"Hasanato","year":"2006","journal-title":"Ann. Saudi Med."},{"issue":"2","key":"10.1016\/j.niox.2024.05.003_bib70","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/BF02894279","article-title":"Pro-oxidant and anti-oxidant status in patients of sickle cell anaemia","volume":"19","author":"Titus","year":"2004","journal-title":"Indian J. Clin. Biochem."},{"key":"10.1016\/j.niox.2024.05.003_bib71","first-page":"542","article-title":"Abnormal vitamin E and glutathione peroxidase levels in sickle cell anemia: evidence for increased susceptibility to lipid peroxidation in vivo","volume":"94","author":"Chiu","year":"1979","journal-title":"J. Lab. Clin. Med."},{"issue":"5","key":"10.1016\/j.niox.2024.05.003_bib72","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/rr70","article-title":"Role of free radicals in the pathogenesis of acute chest syndrome in sickle cell disease","volume":"2","author":"Klings","year":"2001","journal-title":"Respir. Res."},{"issue":"7","key":"10.1016\/j.niox.2024.05.003_bib73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jcla.23294","article-title":"Correlation of lipid peroxidation and nitric oxide metabolites, trace elements, and antioxidant enzymes in patients with sickle cell disease","volume":"34","author":"Antwi-Boasiako","year":"2020","journal-title":"J. Clin. Lab. Anal."},{"issue":"2","key":"10.1016\/j.niox.2024.05.003_bib74","first-page":"17","article-title":"Oxidative profile of patients with sickle cell disease","volume":"7","author":"Antwi-Boasiako","year":"2019","journal-title":"Med. Sci."},{"issue":"1","key":"10.1016\/j.niox.2024.05.003_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10245332.2018.1498441","article-title":"Oxidative stress, antioxidant capacity, biomolecule damage, and inflammation symptoms of sickle cell disease in children","volume":"24","author":"Biswal","year":"2019","journal-title":"Hematology"},{"issue":"7","key":"10.1016\/j.niox.2024.05.003_bib76","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2174\/156652408786241384","article-title":"The role of oxidative stress in hemolytic anemia","volume":"8","author":"Fibach","year":"2008","journal-title":"Curr. Mol. Med."},{"issue":"2","key":"10.1016\/j.niox.2024.05.003_bib77","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/MPH.0000000000001673","article-title":"Effect of high-dose vitamin A supplementation in children Wth icle cell disease: a randomized, double-blind, dose-finding pilot study","volume":"42","author":"Brownell","year":"2020","journal-title":"J. Pediatr. Hematol. Oncol."},{"issue":"4","key":"10.1016\/j.niox.2024.05.003_bib78","doi-asserted-by":"crossref","first-page":"932","DOI":"10.3945\/ajcn.112.035725","article-title":"No improvement in suboptimal vitamin A status with a randomized, double-blind, placebo-controlled trial of vitamin A supplementation in children with sickle cell disease","volume":"96","author":"Dougherty","year":"2012","journal-title":"Am. J. Clin. Nutr."},{"issue":"May","key":"10.1016\/j.niox.2024.05.003_bib79","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.cca.2020.07.020","article-title":"Antioxidant nutrients and hemolysis in sickle cell disease","volume":"510","author":"Delesderrier","year":"2020","journal-title":"Clin. Chim. Acta"},{"issue":"4","key":"10.1016\/j.niox.2024.05.003_bib80","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jtcme.2017.08.002","article-title":"Antioxidant propreties and membrane stabilization effects of methanol extract of Mucuna pruriens leaves on normal and sickle erythrocytes","volume":"9","author":"Anosike","year":"2018","journal-title":"J. Tradic. Complement. Med."},{"key":"10.1016\/j.niox.2024.05.003_bib81","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/1472-6882-13-162","article-title":"The in vitro antisickling and antioxidant effects of aqueous extracts zanthoxyllum heitzii on sickle cell disorder","volume":"13","author":"Pauline","year":"2013","journal-title":"BMC Compl. Alternative Med."},{"issue":"5","key":"10.1016\/j.niox.2024.05.003_bib82","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1177\/0960327117712385","article-title":"Monodora myristica (African Nutmeg) modulates redox Homeostasis and alters functional chemistry in sickled erythrocytes","volume":"37","author":"Erukainure","year":"2018","journal-title":"Hum. Exp. Toxicol."},{"issue":"6","key":"10.1016\/j.niox.2024.05.003_bib83","first-page":"974","article-title":"Resveratrol: antioxidant activity and induction of fetal hemoglobin in erythroid cells from normal donors and \u03b2-thalassemia patients","volume":"29","author":"Fibach","year":"2012","journal-title":"Int. J. Mol. Med."},{"issue":"1","key":"10.1016\/j.niox.2024.05.003_bib84","doi-asserted-by":"crossref","first-page":"52","DOI":"10.5581\/1516-8484.20130015","article-title":"Protective effect of favonoids against reactive oxygen species production in sickle cell anemia patients treated with hydroxyurea","volume":"35","author":"do Nascimento","year":"2013","journal-title":"Rev. Bras. Hematol. Hemoter."},{"issue":"6","key":"10.1016\/j.niox.2024.05.003_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2019.e01905","article-title":"Sickling-preventive effects of rutin is associated with modulation of deoxygenated haemoglobin, 2,3-bisphosphoglycerate mutase, redox status and alteration of functional chemistry in sickle erythrocytes","volume":"5","author":"Muhammad","year":"2019","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.niox.2024.05.003_bib86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12878-017-0075-y","article-title":"Gum Arabic as novel anti-oxidant agent in sickle cell anemia, phase II trial","volume":"17","author":"Kaddam","year":"2017","journal-title":"BMC Hematol."},{"issue":"3","key":"10.1016\/j.niox.2024.05.003_bib87","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.pathophys.2015.05.001","article-title":"L-arginine supplementation enhances antioxidant activity and erythrocyte integrity in sickle cell anaemia subjects","volume":"22","author":"Kehinde","year":"2015","journal-title":"Pathophysiology"},{"issue":"7","key":"10.1016\/j.niox.2024.05.003_bib88","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1007\/s00277-011-1404-z","article-title":"N-acetylcysteine reduces oxidative stress in sickle cell patients","volume":"91","author":"Nur","year":"2012","journal-title":"Ann. Hematol."},{"issue":"5","key":"10.1016\/j.niox.2024.05.003_bib89","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1365-2141.2010.08480.x","article-title":"A pilot study of the short-term use of simvastatin in sickle cell disease: effects on markers of vascular dysfunction","volume":"153","author":"Hoppe","year":"2011","journal-title":"Br. J. Haematol."},{"issue":"4","key":"10.1016\/j.niox.2024.05.003_bib90","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/bjh.14580","article-title":"Simvastatin reduces vaso-occlusive pain in sickle cell anaemia: a pilot efficacy trial","volume":"177","author":"Hoppe","year":"2017","journal-title":"Br. J. Haematol."},{"issue":"6","key":"10.1016\/j.niox.2024.05.003_bib91","first-page":"631","article-title":"Statin therapy: review of safety and potential side effects","volume":"32","author":"Ramkumar","year":"2016","journal-title":"Acta Cardiol. Sin."},{"key":"10.1016\/j.niox.2024.05.003_bib92","first-page":"1","article-title":"Associations between statins and adverse events in primary prevention of cardiovascular disease: systematic review with pairwise, network, and dose-response meta-analyses","volume":"374","author":"Cai","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.niox.2024.05.003_bib93","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1172\/JCI200316672","article-title":"Hydroxyurea induces fetal hemoglobin by the nitric oxide\u2013dependent activation of soluble guanylyl cyclase","volume":"111","author":"Cokic","year":"2003","journal-title":"J. Clin. Investig."},{"issue":"2","key":"10.1016\/j.niox.2024.05.003_bib94","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1046\/j.1365-2141.2002.03274.x","article-title":"Nitric oxide donor properties of hydroxyurea in patients with sickle cell disease","volume":"116","author":"Gladwin","year":"2002","journal-title":"Br. J. Haematol."},{"issue":"7","key":"10.1016\/j.niox.2024.05.003_bib95","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1021\/bi011470o","article-title":"Iron nitrosyl hemoglobin formation from the reactions of hemoglobin and hydroxyurea","volume":"41","author":"Huang","year":"2002","journal-title":"Biochemistry"},{"issue":"13","key":"10.1016\/j.niox.2024.05.003_bib96","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1021\/ja012271v","article-title":"Horseradish peroxidase catalyzed nitric oxide formation from hydroxyurea","volume":"124","author":"Huang","year":"2002","journal-title":"J. Am. Chem. Soc."},{"issue":"14","key":"10.1016\/j.niox.2024.05.003_bib97","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1021\/jm030547z","article-title":"Catalase-mediated nitric oxide formation from hydroxyurea","volume":"47","author":"Huang","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.niox.2024.05.003_bib98","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1172\/JCI200316672","article-title":"Hydroxyurea induces fetal hemoglobin by the nitric oxide \u2013 dependent activation of soluble guanylyl cyclase","volume":"111","author":"Cokic","year":"2003","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.niox.2024.05.003_bib99","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1182\/blood-2007-05-088732","article-title":"Hydroxyurea nitrosylates and activates soluble guanylyl cyclase in human erythroid cells","volume":"111","author":"Cokic","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.niox.2024.05.003_bib100","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.niox.2018.10.003","article-title":"Hydroxyurea therapy modulates sickle cell anemia red blood cell physiology: impact on RBC deformability, oxidative stress, nitrite levels and nitric oxide synthase signalling pathway","volume":"81","author":"Nader","year":"2018","journal-title":"Nitric Oxide - Biol. Chem."},{"issue":"3","key":"10.1016\/j.niox.2024.05.003_bib101","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1365-2141.2005.05772.x","article-title":"Modulation of erythrocyte arginase activity in sickle cell disease patients during hydroxyurea therapy","volume":"131","author":"Iyamu","year":"2005","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.niox.2024.05.003_bib102","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.mvr.2016.04.002","article-title":"Heme changes HIF-\u03b1, ENOS and nitrite production in HUVECs after simvastatin, HU, and ascorbic acid therapies","volume":"106","author":"da Guarda","year":"2016","journal-title":"Microvasc. Res."},{"issue":"6","key":"10.1016\/j.niox.2024.05.003_bib103","doi-asserted-by":"crossref","first-page":"421","DOI":"10.5581\/1516-8484.20120106","article-title":"The influence of hydroxyurea on oxidative stress in sickle cell anemia","volume":"34","author":"Torres","year":"2012","journal-title":"Rev. Bras. Hematol. Hemoter."},{"issue":"July","key":"10.1016\/j.niox.2024.05.003_bib104","first-page":"1","article-title":"Hydroxyurea scavenges free radicals and induces the expression of antioxidant genes in human cell cultures treated with hemin","volume":"11","author":"Santana","year":"2020","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.niox.2024.05.003_bib105","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1177\/1535370219900637","article-title":"L-glutamine for sickle cell disease: knight or pawn?","volume":"245","author":"Sadaf","year":"2020","journal-title":"Exp. Biol. Med."},{"issue":"2","key":"10.1016\/j.niox.2024.05.003_bib106","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/(SICI)1096-8652(199806)58:2<117::AID-AJH5>3.0.CO;2-V","article-title":"Oral L-glutamine therapy for sickle cell anemia: I. Subjective clinical improvement and favorable change in red cell NAD redox potential","volume":"58","author":"Niihara","year":"1998","journal-title":"Am. J. Hematol."},{"issue":"10","key":"10.1016\/j.niox.2024.05.003_bib107","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/01.mph.0000140651.65591.b8","article-title":"Oral glutamine supplementation decreases resting energy expenditure in children and adolescents with sickle cell anemia","volume":"26","author":"Williams","year":"2004","journal-title":"J. Pediatr. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.niox.2024.05.003_bib108","doi-asserted-by":"crossref","DOI":"10.4172\/2167-065X.1000116","article-title":"Glutamine therapy reduces hospitalization for sickle cell anemia and sickle \u03b2\u00b0-thalassemia patients at six months \u2013 a phase II randomized trial","volume":"3","author":"Niihara","year":"2014","journal-title":"Clin. Pharmacol. Biopharm."},{"issue":"3","key":"10.1016\/j.niox.2024.05.003_bib109","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1056\/NEJMoa1715971","article-title":"A phase 3 trial of l -glutamine in sickle cell disease","volume":"379","author":"Niihara","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.niox.2024.05.003_bib110","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1056\/NEJMoa1611770","article-title":"Crizanlizumab for the prevention of pain crises in sickle cell disease","volume":"376","author":"Ataga","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.niox.2024.05.003_bib112","author":"Sa\u00fade"}],"container-title":["Nitric Oxide"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089860324000740?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089860324000740?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T15:06:49Z","timestamp":1727968009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089860324000740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":111,"alternative-id":["S1089860324000740"],"URL":"https:\/\/doi.org\/10.1016\/j.niox.2024.05.003","relation":{},"ISSN":["1089-8603"],"issn-type":[{"value":"1089-8603","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endothelial dysfunction in Sickle Cell Disease: Strategies for the treatment","name":"articletitle","label":"Article Title"},{"value":"Nitric Oxide","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.niox.2024.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}